Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin L Stephans

Showing results (21-30 of 85) with videos related to

Pageof 9
Sort By:
Clinical Lung Cancer|June 16, 2016
Stereotactic Body Radiotherapy for T3N0 Lung Cancer With Chest Wall InvasionCamille Berriochoa, Gregory M M Videtic, Neil M Woody, et al.
Advances in Radiation Oncology|June 13, 2020
Outpatient Anesthesia Facilitates Stereotactic Body Radiation Therapy for Early Stage Lung Cancer Patients With Advanced Cognitive ImpairmentsSenthilkumar Gandhidasan, Chandana A Reddy, Neil M Woody, et al.
International Journal of Radiation Oncology, Biology, Physics|August 3, 2013
Alignment focus of daily image guidance for concurrent treatment of prostate and pelvic lymph nodesSamah Ferjani, Guangshun Huang, Qingyang Shang, et al.
Clinical Genitourinary Cancer|November 18, 2018
Outcomes in Organ Transplant Recipients With Prostate Cancer Treated With RadiotherapySteven C Oh, Muhammad B Tariq, Chandana A Reddy, et al.
International Journal of Radiation Oncology, Biology, Physics|May 18, 2010
Maximum standardized uptake value from staging FDG-PET/CT does not predict treatment outcome for early-stage non-small-cell lung cancer treated with stereotactic body radiotherapyMichael J Burdick, Kevin L Stephans, Chandana A Reddy, et al.
International Journal of Radiation Oncology, Biology, Physics|February 9, 2011
Prediction of chest wall toxicity from lung stereotactic body radiotherapy (SBRT)Kevin L Stephans, Toufik Djemil, Rahul D Tendulkar, et al.
Practical Radiation Oncology|December 12, 2018
Effect of Tumor Location and Dosimetric Predictors for Chest Wall Toxicity in Single-Fraction Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung CancerBindu V Manyam, Gregory M M Videtic, Kyle Verdecchia, et al.
International Journal of Radiation Oncology, Biology, Physics|July 13, 2014
30 Gy or 34 Gy? Comparing 2 single-fraction SBRT dose schedules for stage I medically inoperable non-small cell lung cancerGregory M M Videtic, Kevin L Stephans, Neil M Woody, et al.
Journal of Contemporary Brachytherapy|December 2, 2015
Safety and efficacy of salvage low-dose-rate brachytherapy for prostate bed recurrences following radical prostatectomyAryavarta M S Kumar, Kristin L Smith, Chandana A Reddy, et al.
Cureus|November 10, 2021
Evaluation of Automated Treatment Planning and Organ Dose Prediction for Lung Stereotactic Body RadiotherapyZi Ouyang, Tingliang Zhuang, Gaurav Marwaha, et al.
Pageof 9

Showing results (21-30 of 85) with videos related to

Sort By:
Pageof 9
Clinical Lung Cancer|June 16, 2016
Stereotactic Body Radiotherapy for T3N0 Lung Cancer With Chest Wall InvasionCamille Berriochoa, Gregory M M Videtic, Neil M Woody, et al.
Advances in Radiation Oncology|June 13, 2020
Outpatient Anesthesia Facilitates Stereotactic Body Radiation Therapy for Early Stage Lung Cancer Patients With Advanced Cognitive ImpairmentsSenthilkumar Gandhidasan, Chandana A Reddy, Neil M Woody, et al.
International Journal of Radiation Oncology, Biology, Physics|August 3, 2013
Alignment focus of daily image guidance for concurrent treatment of prostate and pelvic lymph nodesSamah Ferjani, Guangshun Huang, Qingyang Shang, et al.
Clinical Genitourinary Cancer|November 18, 2018
Outcomes in Organ Transplant Recipients With Prostate Cancer Treated With RadiotherapySteven C Oh, Muhammad B Tariq, Chandana A Reddy, et al.
International Journal of Radiation Oncology, Biology, Physics|May 18, 2010
Maximum standardized uptake value from staging FDG-PET/CT does not predict treatment outcome for early-stage non-small-cell lung cancer treated with stereotactic body radiotherapyMichael J Burdick, Kevin L Stephans, Chandana A Reddy, et al.
International Journal of Radiation Oncology, Biology, Physics|February 9, 2011
Prediction of chest wall toxicity from lung stereotactic body radiotherapy (SBRT)Kevin L Stephans, Toufik Djemil, Rahul D Tendulkar, et al.
Practical Radiation Oncology|December 12, 2018
Effect of Tumor Location and Dosimetric Predictors for Chest Wall Toxicity in Single-Fraction Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung CancerBindu V Manyam, Gregory M M Videtic, Kyle Verdecchia, et al.
International Journal of Radiation Oncology, Biology, Physics|July 13, 2014
30 Gy or 34 Gy? Comparing 2 single-fraction SBRT dose schedules for stage I medically inoperable non-small cell lung cancerGregory M M Videtic, Kevin L Stephans, Neil M Woody, et al.
Journal of Contemporary Brachytherapy|December 2, 2015
Safety and efficacy of salvage low-dose-rate brachytherapy for prostate bed recurrences following radical prostatectomyAryavarta M S Kumar, Kristin L Smith, Chandana A Reddy, et al.
Cureus|November 10, 2021
Evaluation of Automated Treatment Planning and Organ Dose Prediction for Lung Stereotactic Body RadiotherapyZi Ouyang, Tingliang Zhuang, Gaurav Marwaha, et al.
Pageof 9